Evidence map›Paper›PMID 36093125›Full record

ArticleNew journal of chemistry = Nouveau journal de chimie2022

Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers.

Nitesh Tamang, Christopher Andrews, Sai Kiran Mavileti, Srinivas Nanduri, Nageswara Rao Golakoti, Balasubramanyam Karanam

Abstract read
In one paragraph

Article in New journal of chemistry = Nouveau journal de chimie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nitesh TamangDepartment of chemistry, Sri Sathya Sai Institute of Higher Learning, Puttaparthi, Andhra Pradesh, India.
Christopher AndrewsDepartment of Biology and Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA.
Sai Kiran MaviletiDepartment of chemistry, Sri Sathya Sai Institute of Higher Learning, Puttaparthi, Andhra Pradesh, India.
Srinivas NanduriDepartment of Process Chemistry, National Institute of Pharmaceutical Education and Research, Balanagar, 500037, Hyderabad, Telangana, India.ORCID 0000-0002-6671-2022
Nageswara Rao GolakotiDepartment of chemistry, Sri Sathya Sai Institute of Higher Learning, Puttaparthi, Andhra Pradesh, India.ORCID 0000-0003-3994-3615
Balasubramanyam KaranamDepartment of Biology and Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA.

Funding

Tuskegee University Center for Biomedical Research/ Research Centers at Minority InstitutionsU54MD007585 · NIMHD · TUSKEGEE UNIVERSITY · PI Balasubramanyam Karanam · 2017 to 2026
$29.4M
Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast CancerR41CA257110 · NCI · UP THERAPEUTICS, INC. · PI ANCHOORI, RAVI KUMAR · 2021 to 2022
$309k
NCI NIH HHS R41 CA257110NIMHD NIH HHS U54 MD007585
6 · The paper itself

Abstract

Acetals (

Identifiers

PMID36093125
PMCPMC9454336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.